Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2020-07-28

Clinical Trial Update: Stereotactic Body Radiotherapy (SBRT) for Localized Prostate Cancer [Phase 2]

View source ↗

Summary

Phase 2 trial update on stereotactic body radiotherapy (SBRT) for localized prostate cancer.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: VA Greater Los Angeles Healthcare System | Conditions: Prostate Cancer | Phase 2 | Status: UNKNOWN